Immunosuppressants
[Immunosuppressants]
EPTIS factsheet 1615923 | Last revision 2026-09-24 | URL: https://www.eptis.bam.de/pts1615923 https://www.eptis.bam.de/pts1615923
| PT provider | |||||||||||||||||||
| PT provider | Birmingham Quality (member of the UK NEQAS Consortium), University Hospitals Birmingham NHS Foundation Trust Birmingham Quality (member of the UK NEQAS Consortium), University Hospitals Birmingham NHS Foundation Trust | ||||||||||||||||||
| Based in | United Kingdom | ||||||||||||||||||
| Language(s) | English | ||||||||||||||||||
| Remarks | Provides EQA coverage and analytical assessment for the Therapeutic drug monitoring of Whole Blood Immunosuppressants: Ciclosporin, Tacrolimus, Sirolimus, Everolimis and Serum Mycophenolate. The Scheme distributes a number of manipulated and endogenous specimens covering a wide concentration range for all analytes. Seperate Specimens are provided for each Immunosuppressant (except for Ciclosporin and Tacrolimus which share the same Specimen). | ||||||||||||||||||
| Keywords | |||||||||||||||||||
| Product groups |
Health care / medical devices
|
||||||||||||||||||
| Testing fields |
Medical analysis
|
||||||||||||||||||
| Technical details | |||||||||||||||||||
|
|||||||||||||||||||
| Aims of the PT scheme | |||||||||||||||||||
| Target group of participants | Clinical Chemistry Public & Private Labs | ||||||||||||||||||
| Linked to specific legislation / standards | ISO/IEC 17043:2023 | ||||||||||||||||||
| Additional, subsidiary aims | Post market surveillance of testing methods | ||||||||||||||||||
| Number of participants | |||||||||||||||||||
| Accredited or otherwise reviewed by a 3rd party |
Accredited by UKAS on the basis of ISO/IEC 17043:2023 |
||||||||||||||||||
| Operation is commissioned / requested by | |||||||||||||||||||
| Fees and frequency | |||||||||||||||||||
| Participation fee | Contact provider for current fee, which depends on location and extent of service required. | ||||||||||||||||||
| Regularly operated | Yes (Monthly (11 per year)) | ||||||||||||||||||
| Year of first operation | 2017 | ||||||||||||||||||
| Contact details of the PT provider | |||||||||||||||||||
| Provider | Contact person | ||||||||||||||||||
|
Birmingham Quality (member of the UK NEQAS Consortium), University Hospitals Birmingham NHS Foundation Trust
Queen Elizabeth Medical Centre P O Box 3909 B15 2SQ Birmingham United Kingdom Phone: +44 121 414 7300 Fax: Web: https://www.birminghamquality.org.uk https://www.birminghamquality.org.uk |
Birmingham Quality
Phone: +44 121 414 7300 Fax: Email: birminghamquality@uhb.nhs.uk birminghamquality@uhb.nhs.uk |
||||||||||||||||||
If you find any mistakes please contact the responsible EPTIS coordinator in United Kingdom,
Mr Savvas Xystouris.
Mr Savvas Xystouris.